Capricor Therapeutics Current Ratio 2012-2025 | CAPR

Capricor Therapeutics current ratio from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Capricor Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2025-09-30 $0.10B $0.03B 3.59
2025-06-30 $0.12B $0.03B 4.37
2025-03-31 $0.15B $0.02B 6.55
2024-12-31 $0.16B $0.02B 7.77
2024-09-30 $0.09B $0.02B 4.19
2024-06-30 $0.03B $0.02B 1.37
2024-03-31 $0.04B $0.03B 1.57
2023-12-31 $0.05B $0.03B 1.63
2023-09-30 $0.03B $0.03B 0.90
2023-06-30 $0.04B $0.04B 1.11
2023-03-31 $0.05B $0.04B 1.26
2022-12-31 $0.04B $0.02B 1.82
2022-09-30 $0.05B $0.02B 2.05
2022-06-30 $0.05B $0.02B 2.69
2022-03-31 $0.06B $0.01B 4.16
2021-12-31 $0.04B $0.00B 8.82
2021-09-30 $0.04B $0.00B 13.82
2021-06-30 $0.04B $0.00B 12.20
2021-03-31 $0.04B $0.00B 11.36
2020-12-31 $0.03B $0.00B 11.33
2020-09-30 $0.04B $0.00B 15.58
2020-06-30 $0.04B $0.00B 19.06
2020-03-31 $0.01B $0.00B 10.39
2019-12-31 $0.01B $0.00B 11.74
2019-09-30 $0.01B $0.00B 7.59
2019-06-30 $0.01B $0.00B 4.24
2019-03-31 $0.01B $0.00B 5.27
2018-12-31 $0.01B $0.00B 6.75
2018-09-30 $0.01B $0.00B 6.07
2018-06-30 $0.01B $0.00B 10.26
2018-03-31 $0.02B $0.00B 9.89
2017-12-31 $0.02B $0.00B 9.41
2017-09-30 $0.02B $0.02B 0.91
2017-06-30 $0.01B $0.02B 0.82
2017-03-31 $0.01B $0.00B 4.08
2016-12-31 $0.02B $0.01B 3.70
2016-09-30 $0.02B $0.01B 3.36
2016-06-30 $0.01B $0.01B 1.90
2016-03-31 $0.02B $0.01B 2.03
2015-12-31 $0.01B $0.01B 2.14
2015-09-30 $0.02B $0.01B 2.71
2015-06-30 $0.02B $0.01B 3.15
2015-03-31 $0.03B $0.01B 3.37
2014-12-31 $0.01B $0.01B 1.84
2014-09-30 $0.01B $0.01B 2.29
2014-06-30 $0.02B $0.01B 2.53
2014-03-31 $0.01B $0.01B 2.23
2013-12-31 $0.00B $0.00B 1.79
2013-09-30 $0.00B $0.00B 0.09
2013-06-30 $0.00B $0.00B 0.29
2013-03-31 $0.00B $0.00B 0.62
2012-12-31 $0.01B $0.00B 9.81
2012-09-30 $0.00B $0.00B 1.53
2012-06-30 $0.00B $0.00B 3.53
2012-03-31 $0.00B $0.00B 1.35
2011-12-31 $0.00B $0.00B 2.42
2011-09-30 $0.00B $0.00B 4.22
2011-06-30 $0.00B $0.00B 8.34
2011-03-31 $0.00B $0.00B 3.16
2010-12-31 $0.00B $0.00B 3.37
2010-09-30 $0.01B $0.00B 3.15
2010-06-30 $0.01B $0.00B 5.05
2010-03-31 $0.00B $0.00B 2.58
2009-12-31 $0.00B $0.00B 5.39
2009-09-30 $0.01B $0.00B 5.39
2009-06-30 $0.00B $0.00B 4.44
2009-03-31 $0.00B $0.00B 5.07
2008-12-31 $0.01B $0.00B 4.54
2008-09-30 $0.01B $0.00B 8.72
2008-06-30 $0.01B $0.00B 10.77
2008-03-31 $0.01B $0.00B 10.71
2007-12-31 $0.02B $0.00B 8.87
2007-09-30 $0.02B $0.00B 13.57
2007-06-30 $0.00B $0.00B 0.00
2007-03-31 $0.00B $0.00B 0.00
2006-12-31 $0.00B $0.00B 0.00
2006-09-30 $0.00B $0.00B 0.00
2006-06-30 $0.00B $0.00B 0.01
2006-03-31 $0.00B $0.00B 0.01
2005-12-31 $0.00B $0.00B 0.00
2005-09-30 $0.00B $0.00B 0.04
2005-06-30 $0.00B $0.00B 0.00
2005-03-31 $0.00B $0.00B 0.04
2004-12-31 $0.00B $0.00B 0.01
2004-09-30 $0.00B $0.00B 0.02
2004-06-30 $0.00B $0.00B 0.07
2004-03-31 $0.00B $0.00B 0.17
2003-12-31 $0.00B $0.00B 0.03
2003-09-30 $0.00B $0.00B 0.00
2003-06-30 $0.00B $0.00B 0.00
2003-03-31 $0.00B $0.00B 0.00
2002-12-31 $0.00B $0.00B 0.00
2002-09-30 $0.00B $0.00B 0.01
2002-06-30 $0.00B $0.00B 0.02
2002-03-31 $0.00B $0.00B 0.70
2001-12-31 $0.00B $0.00B 0.02
2001-09-30 $0.00B 0.00
2001-06-30 $0.00B 0.00
2001-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.111B $0.022B
Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $209.934B 24.19
EssilorLuxottica (ESLOY) France $146.214B 0.00
Stryker (SYK) United States $138.797B 27.56
Boston Scientific (BSX) United States $135.955B 31.09
Medtronic (MDT) Ireland $128.573B 17.81
Medline (MDLN) United States $56.884B 0.00
Lonza Group Ag (LZAGY) Switzerland $49.666B 0.00
Agilent Technologies (A) United States $39.625B 25.05
ResMed (RMD) United States $37.840B 26.19
GE HealthCare Technologies (GEHC) United States $36.943B 17.67
Koninklijke Philips (PHG) Netherlands $28.127B 18.37
Terumo (TRUMY) Japan $20.195B 22.73
Insulet (PODD) United States $20.046B 62.22
Zimmer Biomet Holdings (ZBH) United States $17.153B 10.70
Smith & Nephew SNATS (SNN) United Kingdom $13.928B 0.00
Baxter (BAX) United States $10.132B 8.18
Sunny Optical Technology (SNPTF) China $9.589B 0.00
Bio-Rad Laboratories (BIO) United States $8.404B 30.22
Demant (WILYY) Denmark $7.372B 0.00
Lantheus Holdings (LNTH) United States $4.406B 13.42
Envista Holdings (NVST) United States $4.056B 23.27
BillionToOne (BLLN) United States $3.850B 0.00
ICU Medical (ICUI) United States $3.830B 24.32
Haemonetics (HAE) United States $3.282B 14.61
Prestige Consumer Healthcare (PBH) United States $3.222B 14.69
Shandong Weigao Medical Polymer (SHWGF) China $3.099B 0.00
Neogen (NEOG) United States $2.147B 47.00
Perrigo (PRGO) Ireland $2.052B 5.14
QuidelOrtho (QDEL) United States $1.999B 12.85
LeMaitre Vascular (LMAT) United States $1.973B 39.72
AtriCure (ATRC) United States $1.952B 0.00
Phibro Animal Health (PAHC) United States $1.700B 16.98
Curaleaf Holdings (CURLF) Canada $1.649B 0.00
Green Thumb Industries (GTBIF) United States $1.608B 70.46
Lumexa Imaging Holdings (LMRI) United States $1.431B 0.00
AdaptHealth (AHCO) United States $1.425B 20.63
Kestra Medical Technologies (KMTS) United States $1.377B 0.00
BioLife Solutions (BLFS) United States $1.230B 365.00
Tilray Brands (TLRY) Canada $1.010B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.979B 0.00
InMode (INMD) Israel $0.893B 10.09
Omeros (OMER) United States $0.856B 0.00
Valneva SE (VALN) France $0.854B 0.00
CeriBell (CBLL) United States $0.822B 0.00
VAREX IMAGING (VREX) United States $0.593B 16.08
Verano Holdings (VRNO) United States $0.494B 0.00
Cerus (CERS) United States $0.486B 0.00
Brainsway (BWAY) Israel $0.454B 77.27
Cresco Labs (CRLBF) United States $0.422B 0.00
Canopy Growth (CGC) Canada $0.420B 0.00
SNDL (SNDL) Canada $0.415B 0.00
Quanterix (QTRX) United States $0.329B 0.00
Evolus (EOLS) United States $0.318B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.309B 0.00
Viemed Healthcare (VMD) United States $0.285B 22.70
TriSalus Life Sciences (TLSI) United States $0.276B 0.00
Aurora Cannabis (ACB) Canada $0.240B 141.33
Sanuwave Health (SNWV) United States $0.236B 0.00
TerrAscend (TSNDF) Canada $0.234B 0.00
High Tide (HITI) Canada $0.228B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Organigram Global (OGI) Canada $0.216B 0.00
Sanara MedTech (SMTI) United States $0.203B 0.00
Utah Medical Products (UTMD) United States $0.201B 17.73
OraSure Technologies (OSUR) United States $0.199B 0.00
Vireo Growth (VREOF) United States $0.170B 0.00
Accendra Health (ACH) United States $0.166B 1.66
Quipt Home Medical (QIPT) United States $0.157B 0.00
FitLife Brands (FTLF) United States $0.156B 0.00
Apyx Medical (APYX) United States $0.153B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.137B 0.00
Fonar (FONR) United States $0.116B 16.84
Jushi Holdings (JUSHF) United States $0.114B 0.00
MacroGenics (MGNX) United States $0.110B 0.00
Exagen (XGN) United States $0.107B 0.00
Biote (BTMD) United States $0.105B 4.58
Sharps Technology (STSS) United States $0.065B 0.00
ImmuCell (ICCC) United States $0.062B 26.15
Rockwell Medical (RMTI) United States $0.048B 0.00
Nephros (NEPH) United States $0.048B 35.08
Cytosorbents (CTSO) United States $0.043B 0.00
Veru (VERU) United States $0.042B 0.00
Modular Medical (MODD) United States $0.036B 0.00
United-Guardian (UG) United States $0.030B 15.19
Bonk (BNKK) United States $0.025B 0.00
Jin Medical (ZJYL) China $0.020B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
INLIF (INLF) China $0.008B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Flora Growth (FLGC) United States $0.007B 0.00
Agape ATP (ATPC) $0.004B 0.00
Zynex (ZYXI) United States $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
Akanda (AKAN) Canada $0.000B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00